DuPont Changing Labels For Antiseptic Products To Comply With FDA Warning
This article was originally published in The Tan Sheet
Executive Summary
DuPont plans by the end of June to comply with FDA's warning to change the labels for its RelyOn antiseptic spray and hand-wipe products that include disease claims not approved in a pending monograph for OTC health care antiseptics or in the topical antifungal drug products monographYou may also be interested in...
FDA Budget Reaffirms Commitment To OTCs, Reduces Supplement Programs
FDA hopes to increase the number of over-the-counter drugs on the market as part of its long-term goal to provide consumers with safe, effective and affordable drugs, the agency states in its fiscal year 2007 budget request presentation
Antiseptic Products “Not Effective” In Reducing Skin Infection – FDA
No available evidence demonstrates that consumer antiseptic products reduce the risk of skin infection and such indications should not be included in the drug monograph, Office of Nonprescription Products reviewers say
CBD Safety And Hemp Farming Have Equal Space In Rep. Harris’ Concerns
“We ought to deal with this. There are questions on long-term safety and questions on efficacy claims that are just not proven,” says the Maryland Republican. “The biggest threat hanging over, in my mind, the farmers who want to grow hemp, is what if the FDA comes out tomorrow and says, ‘You can't sell any product’? The market collapses,”he said at a CBD policy conference.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports
New to Pink Sheet?
Start a free trial today!
Register for our free email digests:
Register for our free email digests: